Regional authorities bet on biotech

Published: 2011-09-22 06:59:00

Updated: 2011-09-22 06:59:00

Biosimilars are widely seen as a new engine of Korea’s economic growth. The market for the industry is projected to grow to $14.3 billion by 2015, especially after 2013 when patents for major innovator pharmaceuticals expire, according to the Ministry of Knowledge Economy.

Korea also desires t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK